Denali Therapeutics
DNLI
#4170
Rank
A$3.98 B
Marketcap
A$25.54
Share price
0.78%
Change (1 day)
-26.04%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: A$3.98 Billion

As of December 2025 Denali Therapeutics has a market cap of A$3.98 Billion. This makes Denali Therapeutics the world's 4170th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2025

End of year Market Cap

Year Marketcap Change
2025A$3.98 B-16.38%
2024A$4.76 B9.55%
2023A$4.35 B-21.57%
2022A$5.55 B-26.12%
2021A$7.51 B-42.49%
2020A$13.06 B445.81%
2019A$2.39 B-13.79%
2018A$2.77 B57.51%
2017A$1.76 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Denali Therapeutics was reported to be:

A$3.94 Billion
by Nasdaq info icon info icon
A$3.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
A$2.15 B-46.07% Jersey
Novavax
NVAX
A$1.64 B-58.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
A$5.54 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$0.57 B-85.60%๐Ÿ‡ฌ๐Ÿ‡ง UK